Bühring K U, Metallinos A, Jakobs N, von Landenberg F, Merck E
Institut für Toxikologie, Darmstadt, FRG.
Lens Eye Toxic Res. 1990;7(3-4):335-45.
Beagles were treated with bisoprolol, a beta 1-selective adrenoceptor antagonist, for 30 days with the following daily doses: oral: 30 mg/kg; conjunctival: 0.5% solution (approx. 0.04 mg/kg) and 5% solution (approx. 0.4 mg/kg). Drug concentrations were determined in plasma and various eye tissues on days 1, 16, and 30, and on day 59, i.e. on day 29 of the follow-up period. Bisoprolol concentrations in plasma and most eye tissues were considerably higher after oral than after conjunctival treatment. The highest tissue concentrations were observed in the iris (+ciliary body) and retina (+choroid) with tissue/plasma concentration ratios between 100 and 150 after oral and 1000 to 3000 after conjunctival instillation (5% solution). In plasma no accumulation of the drug was observed which is in accordance with its plasma half-life of 4 to 5 h. In contrast to this, concentrations in the iris and retina increased from day 1 to day 16 and 30 by 3 to 8 times and the half-life of bisoprolol in these tissues was estimated to be between 3 to 5 days.
用比索洛尔(一种β1选择性肾上腺素能受体拮抗剂)对小猎犬进行为期30天的治疗,每日剂量如下:口服:30毫克/千克;结膜给药:0.5%溶液(约0.04毫克/千克)和5%溶液(约0.4毫克/千克)。在第1、16和30天以及第59天(即随访期的第29天)测定血浆和各种眼组织中的药物浓度。口服给药后血浆和大多数眼组织中的比索洛尔浓度明显高于结膜给药后。虹膜(+睫状体)和视网膜(+脉络膜)中的组织浓度最高,口服给药后组织/血浆浓度比在100至150之间,结膜滴注(5%溶液)后在1000至3000之间。在血浆中未观察到药物蓄积,这与其4至5小时的血浆半衰期一致。与此相反,虹膜和视网膜中的浓度从第1天到第16天和第30天增加了3至8倍,比索洛尔在这些组织中的半衰期估计在3至5天之间。